42
|
113
|
7nq0AAA |
C-terminal bromodomain of human brd2 with oxabicyclo(hexan-6-yl)-n2-methyl-6-((s)-1-phenylethyl)pyridine-2,4-dicarboxamide |
42
|
126
|
7mlqA |
X-ray crystal structure of human brd4(d1) in complex with 2-(4-{5-[6-(2,5-dibromophenoxy)pyridin-2-yl]-4-methyl-1h-1,2,3-triazol-1-yl}piperidin-1-yl)-n,n-dimethylethan-1-amine (compound 26) |
43
|
126
|
7mlsA |
X-ray crystal structure of human brd4(d1) in complex with 2-(2,5-dibromophenoxy)-6-[4-methyl-1-(piperidin-4-yl)-1h-1,2,3-triazol-5-yl]pyridine (compound 23) |
45
|
112
|
7npzAAA |
C-terminal bromodomain of human brd2 with (r)-n5-cyclopropyl-n3-methyl-2-oxo-1-(1-phenylethyl)-1,2-dihydropyridine-3,5-dicarboxamide |
41
|
112
|
7nq2AAA |
C-terminal bromodomain of human brd2 with (s)-n4-cyclopropyl-n2-methyl-6-(1-phenylethyl)pyridine-2,4-dicarboxamide |
43
|
126
|
7mlrA |
X-ray crystal structure of human brd4(d1) in complex with 2-(4-{5-[6-(3,5-dimethylphenoxy)pyridin-2-yl]-4-methyl-1h-1,2,3-triazol-1- yl}piperidin-1-yl)-n,n-dimethylethan-1-amine (dw34) |
43
|
111
|
7npyAAA |
C-terminal bromodomain of human brd2 with 6-benzyl-n2-methyl-n4-((1s,2s)-2-methylcyclopropyl)pyridine-2,4-dicarboxamide |
98
|
248
|
7lb0A |
Crystal structure of the tandem bromodomain (bd1, bd2) of human taf1 bound to zs1-295 |
41
|
120
|
7lakA |
Crystal structure of the first bromodomain (bd1) of human brd2 bound to volasertib |
42
|
118
|
7lazA |
Crystal structure of the first bromodomain (bd1) of human brd3 bound to erk5-in-1 |
44
|
121
|
7layA |
Crystal structure of the first bromodomain (bd1) of human brd3 bound to sg3-179 |
46
|
122
|
7jt4A |
Crystal structure of bptf bromodomain labelled with 5-fluoro-tryptophan |
99
|
247
|
7lb2A |
Crystal structure of the tandem bromodomain (bd1, bd2) of human taf1 bound to zs1-589 |
45
|
121
|
7lejA |
Crystal structure of the second bromodomain (bd2) of human brdt bound to volasertib |
100
|
249
|
7lb1A |
Crystal structure of the tandem bromodomain (bd1, bd2) of human taf1 bound to zs1-585 |
41
|
114
|
7lelA |
Crystal structure of the second bromodomain (bd2) of human brdt bound to bromosporine |
41
|
112
|
7lekA |
Crystal structure of the second bromodomain (bd2) of human brdt bound to erk5-in-1 |
37
|
108
|
7lemA |
Crystal structure of the first bromodomain (bd1) of human brdt bound to lrrk2-in-1 |
39
|
111
|
7lbtA |
Crystal structure of the second bromodomain (bd2) of human brd3 bound to erk5-in-1 |
40
|
108
|
7lb4A |
Crystal structure of the second bromodomain (bd2) of human brd3 bound to bromosporine |
43
|
110
|
7l9jA |
Crystal structure of the second bromodomain (bd2) of human brd2 bound to ro3280 |
41
|
112
|
7l9kA |
Crystal structure of the second bromodomain (bd2) of human brd2 bound to lrrk2-in-1 |
42
|
113
|
7l9lA |
Crystal structure of the second bromodomain (bd2) of human brd3 bound to bi2536 |
40
|
110
|
7l6dA |
Crystal structure of the second bromodomain (bd2) of human brd2 bound to bromosporine |
101
|
256
|
7l6xA |
Crystal structure of the tandem bromodomain (bd1, bd2) of human taf1 bound to gne-371 |
44
|
113
|
7l99A |
Crystal structure of brdt bromodomain 2 in complex with cdd-1302 |
43
|
118
|
7l9aA |
Crystal structure of brdt bromodomain 2 in complex with cdd-1102 |
38
|
112
|
7l73A |
Crystal structure of the first bromodomain (bd1) of human brdt bound to erk5-in-1 |
41
|
127
|
7jkxA |
Bromodomain-containing protein 4 (brd4) bromodomain 1 (bd1) complexed with yf3-6 |
103
|
247
|
7n42A |
Crystal structure of the tandem bromodomain of human taf1 (taf1-t) bound to zs1-681 |
130
|
865
|
7enaDA |
Tfiid-based pic-mediator holo-complex in pre-assembled state (pre-hpic-med) |
51
|
124
|
7m97A |
Crystal structure of the bromodomain from plasmodium falciparum bromodomain protein 1 |
32
|
108
|
7mcfA |
Crystal structure of the first bromodomain of human brd4 in complex with 2-{3-(1,4-dimethyl-1h-1,2,3-triazol-5-yl)-6-fluoro-5-[(s)-(3-fluoropyridin-2-yl)(oxan-4-yl)methyl]-5h-pyrido[3,2-b]indol-7-yl}propan-2-ol |
120
|
865
|
7encDA |
Tfiid-based pic-mediator holo-complex in fully-assembled state (hpic-med) |
41
|
115
|
7kpyA |
Crystal structure of cbp bromodomain liganded with umb298 (compound 23) |
36
|
105
|
7c6pA |
Bromodomain-containing 4 bd2 in complex with 3',4',7,8- tetrahydroxyflavonoid |
46
|
125
|
7c2zA |
Bromodomain-containing 4 bd1 in complex with 3',4',7,8-tetrahydroxyflavone |
123
|
865
|
7edxA |
P53-bound tfiid-based core pic on hdm2 promoter |
132
|
865
|
7egaA |
Tfiid-based intermediate pic on puma promoter |
134
|
865
|
7eg8A |
Tfiid-based core pic on puma promoter |
128
|
865
|
7eg9A |
Tfiid-based intermediate pic on scp promoter |
128
|
865
|
7eg7A |
Tfiid-based core pic on scp promoter |
114
|
865
|
7egbA |
Tfiid-based holo pic on scp promoter |
45
|
114
|
6y7kA |
Structure of the brd9 bromodomain and compound 27 |
43
|
113
|
6y7jA |
Structure of the brd9 bromodomain and compound 15 |
44
|
112
|
7nqjA |
C-terminal bromodomain of human brd2 with n-ethyl-2-(1-methyl-1h-1,2,3-triazol-4-yl)-6-(1-phenylethyl)isonicotinamide |
43
|
114
|
6y7hA |
Structure of the brd9 bromodomain and compound 11 |
41
|
113
|
6y7lA |
Structure of the brd9 bromodomain and tp-472 |
42
|
114
|
6y7iA |
Structure of the brd9 bromodomain and compound 2 |
44
|
117
|
7bbpAAA |
Crystal structure of the second bromodomain of pleckstrin homology domain interacting protein (phip) in complex with h4k5ack8ac |